• 1. An integrated droplet-digital microfluidic system for on-demand droplet creation, mixing, incubation, and sorting?
  Lab Chip, 2019,19, 524-535
• 2. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 3. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 4. An investigation on the interaction modes of a single-strand DNA aptamer and RBP4 protein: a molecular dynamic simulations approach?
  Raheleh Torabi,Hedayatollah Ghourchian,Massoud Amanlou Org. Biomol. Chem., 2016,14, 8141-8153
• 5. An alkynylboronatecycloaddition strategy to functionalised benzyne derivatives?
  James D. Kirkham,Patrick M. Delaney,George J. Ellames,Eleanor C. Row,Joseph P. A. Harrity Chem. Commun., 2010,46, 5154-5156

Professional Introduction to CAS No 16773-51-6 and Product Name: 2-Oxiranylmethyl Ornidazole

CAS No 16773-51-6 refers to a specific chemical compound that has garnered significant attention in the field of pharmaceutical chemistry and biomedicine. This compound, known by the product name: 2-Oxiranylmethyl Ornidazole, is a derivative of Ornidazole, a well-established antiprotozoal and antibacterial agent. The unique structural feature of this compound lies in its 2-oxiranylmethyl side chain, which imparts distinct reactivity and potential therapeutic applications. This introduction delves into the chemical properties, synthesis, pharmacological significance, and recent research developments associated with this compound.

The molecular structure of CAS No 16773-51-6 consists of an Ornidazole core substituted with a 2-oxiranylmethyl group. Ornidazole itself is a nitroimidazole derivative, widely recognized for its efficacy against anaerobic bacteria and protozoan parasites. The introduction of the 2-oxiranylmethyl moiety modifies the electronic and steric properties of the molecule, potentially enhancing its interaction with biological targets. This modification has opened new avenues for drug design, particularly in developing novel antimicrobial agents with improved pharmacokinetic profiles.

In terms of chemical synthesis, the preparation of CAS No 16773-51-6 involves a multi-step process that typically begins with the functionalization of the Ornidazole scaffold. The 2-oxiranylmethyl group is introduced through nucleophilic addition or ring-opening reactions of epoxide precursors. Advanced synthetic methodologies, such as transition-metal-catalyzed cross-coupling reactions or organometallic chemistry, have been employed to achieve high yields and purity. These synthetic approaches not only highlight the compound's synthetic accessibility but also underscore the growing sophistication in medicinal chemistry techniques.

The pharmacological potential of product name: 2-Oxiranylmethyl Ornidazole has been extensively explored in recent years. Studies have demonstrated that the 2-oxiranylmethyl group can enhance the binding affinity to bacterial enzymes and protozoan proteins, leading to improved therapeutic efficacy. Additionally, this derivative exhibits promising activity against drug-resistant strains, making it a valuable candidate for addressing emerging infectious diseases. Preclinical studies have shown that CAS No 16773-51-6 possesses favorable pharmacokinetic properties, including enhanced bioavailability and reduced toxicity compared to its parent compound.

Recent research in the field has focused on leveraging computational chemistry and molecular modeling to optimize the structure-activity relationships (SAR) of product name: 2-Oxiranylmethyl Ornidazole. By integrating high-throughput screening (HTS) data with quantum mechanical calculations, researchers have identified key structural features that contribute to its antimicrobial activity. These insights have guided the development of next-generation derivatives with improved potency and selectivity. Furthermore, advances in biopharmaceutical technology have enabled detailed mechanistic studies, elucidating how this compound interacts with biological targets at the molecular level.

The clinical significance of CAS No 16773-51-6 is further underscored by its potential applications in treating infections caused by multidrug-resistant pathogens. In regions where antibiotic resistance is prevalent, compounds like product name: 2-Oxiranylmethyl Ornidazole offer a ray of hope by providing alternative therapeutic options. Clinical trials are currently underway to evaluate its efficacy and safety in human populations. Preliminary results are promising, indicating that this derivative may serve as a cornerstone in future antimicrobial strategies.

Beyond its therapeutic applications, CAS No 16773-51-6 has sparked interest in academic and industrial research for its potential use as a scaffold for drug discovery. The versatility of the 2-oxiranylmethyl group allows for further chemical modifications, enabling the creation of libraries of novel compounds with diverse biological activities. Collaborative efforts between academia and pharmaceutical companies are underway to explore these possibilities further. Such initiatives not only foster innovation but also contribute to building a robust pipeline for next-generation therapeutics.

The environmental impact and sustainability considerations associated with product name: 2-Oxiranylmethyl Ornidazole are also gaining traction in research discussions. Efforts are being made to develop greener synthetic routes that minimize waste generation and energy consumption. Additionally, studies are investigating the biodegradability and ecological safety of this compound to ensure its responsible use in pharmaceutical applications. These efforts align with global trends toward sustainable chemistry practices.

In conclusion,CAS No 16773-51-6, particularly when referred to as product name: 2-Oxiranylmethyl Ornidazole, represents a significant advancement in antimicrobial drug development. Its unique structural features, coupled with promising pharmacological properties, position it as a promising candidate for addressing infectious diseases caused by resistant pathogens. Ongoing research continues to uncover new insights into its mechanism of action and therapeutic potential, reinforcing its importance in modern medicine.

• 443-48-1(Metronidazole)
• 696-23-1(2-Methyl-5-nitroimidazole)
• 1077-93-6(2-Methyl-5-nitroimidazole-1-propanol)
• 13182-89-3(Metronidazole benzoate)
• 6506-37-2(Nimorazole)
• 936-05-0(HMMNI)
• 16156-90-4(1-(2-iodoethyl)-2-methyl-5-nitro-1h-imidazole)
• 3366-95-8(secnidazole)
• 551-92-8(Dimetridazole)
• 16773-52-7(2-Methyl-5-nitro-1-(2-oxiranylmethyl)-1H-imidazole)